FPF
BMRN icon

First Pacific Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

First Pacific Financial’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29
Closed -$2.53K – 393
2024
Q1 		$2.53K Buy
29
+9
+45% +$806 ﹤0.01% 344
2023
Q4 		$1.93K Buy
+20
New +$1.77K ﹤0.01% 313

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

First Pacific Financial's BMRN Position: Q2 2024 in Review

First Pacific Financial sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2024, closing a stake of 29 shares — an estimated $2.53K sold.

First Pacific Financial first reported a position in BMRN in Q4 2023 and held it in 2 quarters. The position peaked at $2.53K in Q1 2024. 558 funds tracked by Wall St. Rank hold BMRN as of Q2 2024.

  • First Pacific Financial reported no remaining BioMarin Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • First Pacific Financial sold 29 BioMarin Pharmaceuticals shares in Q2 2024, an estimated $2.53K.
  • First Pacific Financial first reported a position in BioMarin Pharmaceuticals in Q4 2023 and held it in 2 quarters.
  • First Pacific Financial's BioMarin Pharmaceuticals position peaked at $2.53K in Q1 2024.
  • 558 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2024.

Based on First Pacific Financial's 13F filing for Q2 2024, filed 19 Jul 2024.